NR4A1 and metabolic disease: Recent research has proposed ten ‘key characteristics’ of endocrine-disrupting chemicals, highlighting that EDCs may affect hormone receptors, alter hormone synthesis, transport or signaling, and thereby provoke diverse adverse health outcomes including reproductive dysfunction, metabolic disorders or cancer [226].